# A Clinical Trial Evaluating Efficacy and Safety of MC2-01 Cream

> **NCT03308799** · PHASE3 · COMPLETED · sponsor: **MC2 Therapeutics** · enrollment: 794 (actual)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **DRUG:** MC2-01 cream
- **DRUG:** Cal/BDP combination
- **DRUG:** Cream vehicle

## Key facts

- **NCT ID:** NCT03308799
- **Lead sponsor:** MC2 Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-03
- **Primary completion:** 2018-06-08
- **Final completion:** 2018-06-08
- **Target enrollment:** 794 (ACTUAL)
- **Last updated:** 2024-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03308799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03308799, "A Clinical Trial Evaluating Efficacy and Safety of MC2-01 Cream". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03308799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*